Federal Appeals Court Affirms Sun Pharma’s Generic Prevacid Following Takeda Patent Suit

Drug Industry Daily
A A
The U.S. Court of Appeals for the Federal Circuit upheld a lower court decision that Sun Pharma did not infringe on Takeda’s patents when developing a generic version of Prevacid disintegrating tablets.

To View This Article:

Login

Subscribe To Drug Industry Daily